Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations

MLA

Hsin-Pin Ho Liang, et al. Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations. May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....73c4796489044a91794000c22f649cf4&authtype=sso&custid=ns315887.

APA

Hsin-Pin Ho Liang, Padmini Salgame, Brendan Prideaux, Firat Kaya, Jansy Sarathy, Marizel Mina, Jillian Dietzold, Denise E. Kirschner, Nadine Alvarez-Cabrera, Véronique Dartois, Landry Blanc, Paul O’Brien, Radojka M. Savic, Elsje Pienaar, Isabela Dias-Freedman, Matthew D. Zimmerman, & Jennifer J. Linderman. (2019). Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations.

Chicago

Hsin-Pin Ho Liang, Padmini Salgame, Brendan Prideaux, Firat Kaya, Jansy Sarathy, Marizel Mina, Jillian Dietzold, et al. 2019. “Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....73c4796489044a91794000c22f649cf4&authtype=sso&custid=ns315887.